Search Results 1171-1180 of 15159 for sids
Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.
Publications · Yadav S, Katamesh BE, Vincent A. · Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, Grach SL, Overgaard J, Snyder MR, Collins NM, ...
Dr. Reisenauer: We implement a multidisciplinary team which involves people with research expertise so that patients are exposed to clinical trials. Dr.
Search for a doctor. James A. Yiannias, M.D.. Dermatologist. Request an Appointment · Overview · Publications. Patient Stories. Print. PST-20221785.
The purpose of this study is to see how the DNA methylation (a biochemical process involved in cell development) is activated during initial tumor growth and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of the study is to determine if low doses of BNP can improve renal function in people with chronic heart failure with renal dysfunction, also to ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
The purpose of this study is to define the change or “delta” in platelet function tests that represents a significant change in patient condition, to facilitate ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact.